SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '27S'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.73A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.51A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227GLU A 277 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-3.4A) | 0.79A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.17A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.05A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.22A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.64A | 1a4gA-4mjuA:52.2 | 1a4gA-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.72A | 1a4gB-4mjuA:52.2 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 1a4gB-4mjuA:52.2 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 118ARG A 224ALA A 246GLU A 276 | 27S A 501 (-3.1A)27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A) | 1.33A | 1a4gB-4mjuA:52.2 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.18A | 1a4gB-4mjuA:52.2 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.07A | 1a4gB-4mjuA:52.2 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ILE A 222 | 27S A 501 (-3.2A)27S A 501 (-4.2A)27S A 501 ( 4.6A) | 0.71A | 1a4gB-4mjuA:52.1 | 1a4gB-4mjuA:36.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.01A | 1l7fA-4mjuA:62.6 | 1l7fA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | LEU A 134ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | NoneNoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.40A | 1l7fA-4mjuA:62.6 | 1l7fA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277 | None27S A 501 (-3.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 0.65A | 1l7fA-4mjuA:62.6 | 1l7fA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-3.1A) | 0.51A | 1l7fA-4mjuA:62.6 | 1l7fA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.43A | 1l7gA-4mjuA:62.6 | 1l7gA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276 | None27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A) | 0.70A | 1l7gA-4mjuA:62.6 | 1l7gA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.4A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 1.05A | 1l7hA-4mjuA:62.5 | 1l7hA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | LEU A 134ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | NoneNoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.39A | 1l7hA-4mjuA:62.5 | 1l7hA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276 | None27S A 501 (-3.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A) | 0.67A | 1l7hA-4mjuA:62.5 | 1l7hA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-3.1A) | 0.48A | 1l7hA-4mjuA:62.5 | 1l7hA-4mjuA:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.62A | 1nncA-4mjuA:61.9 | 1nncA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.02A | 1nncA-4mjuA:61.9 | 1nncA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 156TRP A 178ILE A 222 | 27S A 501 (-3.2A)NoneNone27S A 501 ( 4.6A) | 0.71A | 1nncA-4mjuA:61.9 | 1nncA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.61A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.39A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.75A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.04A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.93A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.19A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.62A | 2cmlA-4mjuA:62.7 | 2cmlA-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.53A | 2cmlB-4mjuA:62.8 | 2cmlB-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246ASN A 294ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.6A)27S A 501 (-3.1A) | 0.75A | 2cmlB-4mjuA:62.8 | 2cmlB-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.99A | 2cmlB-4mjuA:62.8 | 2cmlB-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.25A | 2cmlB-4mjuA:62.8 | 2cmlB-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.57A | 2cmlB-4mjuA:62.8 | 2cmlB-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.59A | 2cmlC-4mjuA:62.7 | 2cmlC-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.91A | 2cmlC-4mjuA:62.7 | 2cmlC-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.01A | 2cmlC-4mjuA:62.7 | 2cmlC-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.25A | 2cmlC-4mjuA:62.7 | 2cmlC-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.59A | 2cmlC-4mjuA:62.7 | 2cmlC-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 2cmlD-4mjuA:62.7 | 2cmlD-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246ASN A 294ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.6A)27S A 501 (-3.1A) | 0.78A | 2cmlD-4mjuA:62.7 | 2cmlD-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.01A | 2cmlD-4mjuA:62.7 | 2cmlD-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.18A | 2cmlD-4mjuA:62.7 | 2cmlD-4mjuA:48.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.63A | 2cmlD-4mjuA:62.7 | 2cmlD-4mjuA:48.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.40A | 2f0zA-4mjuA:6.6 | 2f0zA-4mjuA:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156GLU A 277ARG A 292ARG A 371TYR A 406 | None27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.93A | 2f0zA-4mjuA:6.6 | 2f0zA-4mjuA:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.41A | 2f10A-4mjuA:9.1 | 2f10A-4mjuA:21.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 152ARG A 156GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)None27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.75A | 2htqA-4mjuA:72.0 | 2htqA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 152ARG A 156GLU A 227ALA A 246GLU A 277ARG A 292TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)None27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.71A | 2htqA-4mjuA:72.0 | 2htqA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 152ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.16A | 2htqA-4mjuA:72.0 | 2htqA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152TRP A 178ILE A 222ARG A 224GLU A 276ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)None27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.95A | 2htuA-4mjuA:73.7 | 2htuA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ARG A 224GLU A 276ARG A 292TYR A 347TYR A 406 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.1A)None27S A 501 (-4.6A) | 0.61A | 2htuA-4mjuA:73.7 | 2htuA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ILE A 222ARG A 224GLU A 276ARG A 292TYR A 406 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.47A | 2htuA-4mjuA:73.7 | 2htuA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 118ASP A 151GLU A 227ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 (-3.1A) | 0.78A | 2htuA-4mjuA:73.7 | 2htuA-4mjuA:98.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 3b7eA-4mjuA:67.3 | 3b7eA-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.02A | 3b7eA-4mjuA:67.3 | 3b7eA-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.65A | 3b7eA-4mjuA:67.3 | 3b7eA-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 3b7eB-4mjuA:67.1 | 3b7eB-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.02A | 3b7eB-4mjuA:67.1 | 3b7eB-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.62A | 3b7eB-4mjuA:67.1 | 3b7eB-4mjuA:56.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 152GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.70A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 152GLU A 227GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.38A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 152GLU A 119TYR A 347ARG A 371TYR A 406 | 27S A 501 (-4.2A)27S A 501 (-3.4A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.24A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119ARG A 152GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.02A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 6 | ASP A 151ARG A 156TRP A 178ARG A 224 | 27S A 501 (-3.2A)NoneNone27S A 501 (-4.3A) | 1.05A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 6 | ASP A 151TRP A 178ILE A 222ARG A 224 | 27S A 501 (-3.2A)None27S A 501 ( 4.6A)27S A 501 (-4.3A) | 0.70A | 3ckzA-4mjuA:67.2 | 3ckzA-4mjuA:56.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HRD_E_NIOE5660_1 (NICOTINATEDEHYDROGENASE LARGEMOLYBDOPTERINSUBUNITNICOTINATEDEHYDROGENASE MEDIUMMOLYBDOPTERINSUBUNIT) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | GLU A 227GLU A 277TRP A 423 | 27S A 501 (-3.3A)27S A 501 (-3.4A)None | 0.90A | 3hrdA-4mjuA:undetectable3hrdE-4mjuA:undetectable3hrdF-4mjuA:undetectable | 3hrdA-4mjuA:21.513hrdE-4mjuA:21.513hrdF-4mjuA:23.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)NoneNoneNone27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.56A | 3k37A-4mjuA:52.2 | 3k37A-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134TRP A 178ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)NoneNone27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.01A | 3k37A-4mjuA:52.2 | 3k37A-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371 | 27S A 501 (-3.0A)NoneNoneNone27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A) | 0.52A | 3k37B-4mjuA:52.1 | 3k37B-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118LEU A 134ASP A 151ARG A 156TRP A 178GLU A 227ARG A 371 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)NoneNone27S A 501 (-3.3A)27S A 501 (-3.1A) | 0.76A | 3k37B-4mjuA:52.1 | 3k37B-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119LEU A 134TRP A 178ARG A 224ALA A 246GLU A 277ARG A 292 | 27S A 501 (-3.4A)NoneNone27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.11A | 3k37B-4mjuA:52.1 | 3k37B-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152GLU A 276TYR A 406 | 27S A 501 (-4.2A)27S A 501 ( 3.7A)27S A 501 (-4.6A) | 0.79A | 3k37B-4mjuA:52.1 | 3k37B-4mjuA:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 3k39A-4mjuA:51.4 | 3k39A-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.03A | 3k39A-4mjuA:51.4 | 3k39A-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.98A | 3k39A-4mjuA:51.4 | 3k39A-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.91A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.06A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.98A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119GLU A 277 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 (-3.4A) | 1.19A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.47A | 3k39B-4mjuA:51.6 | 3k39B-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.71A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.90A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.42A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.08A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.00A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119GLU A 277 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 (-3.4A) | 1.19A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.46A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A) | 1.03A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371 | None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A) | 0.69A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292ARG A 371 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A) | 0.99A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119GLU A 277ARG A 371 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.22A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 227GLU A 277ARG A 371 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.00A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.47A | 3k39D-4mjuA:51.6 | 3k39D-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 3k39E-4mjuA:51.5 | 3k39E-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 3k39E-4mjuA:51.5 | 3k39E-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.00A | 3k39E-4mjuA:51.5 | 3k39E-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.67A | 3k39F-4mjuA:51.7 | 3k39F-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 3k39F-4mjuA:51.7 | 3k39F-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 3k39F-4mjuA:51.7 | 3k39F-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 3k39G-4mjuA:51.5 | 3k39G-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.03A | 3k39G-4mjuA:51.5 | 3k39G-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.00A | 3k39G-4mjuA:51.5 | 3k39G-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.67A | 3k39H-4mjuA:51.5 | 3k39H-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.03A | 3k39H-4mjuA:51.5 | 3k39H-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.01A | 3k39H-4mjuA:51.5 | 3k39H-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.72A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.90A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.41A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.09A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A) | 1.02A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.99A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.45A | 3k39I-4mjuA:51.6 | 3k39I-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.71A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None | 1.00A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.40A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.08A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A) | 1.02A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 1.02A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.47A | 3k39J-4mjuA:51.6 | 3k39J-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.70A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.91A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.41A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.08A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.00A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119GLU A 277 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 (-3.4A) | 1.19A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.46A | 3k39K-4mjuA:51.7 | 3k39K-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.71A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.91A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.42A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.09A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A) | 1.02A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 1.01A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.48A | 3k39L-4mjuA:51.5 | 3k39L-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.67A | 3k39M-4mjuA:51.5 | 3k39M-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 3k39M-4mjuA:51.5 | 3k39M-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.01A | 3k39M-4mjuA:51.5 | 3k39M-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.98A | 3k39N-4mjuA:51.7 | 3k39N-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.65A | 3k39N-4mjuA:51.7 | 3k39N-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292ARG A 371TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.97A | 3k39N-4mjuA:51.7 | 3k39N-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.66A | 3k39O-4mjuA:51.7 | 3k39O-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118LEU A 134ARG A 152GLU A 227ARG A 371 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)27S A 501 (-3.3A)27S A 501 (-3.1A) | 1.47A | 3k39O-4mjuA:51.7 | 3k39O-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 3k39O-4mjuA:51.7 | 3k39O-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 371TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.01A | 3k39O-4mjuA:51.7 | 3k39O-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.98A | 3k39P-4mjuA:51.6 | 3k39P-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.66A | 3k39P-4mjuA:51.6 | 3k39P-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246ARG A 292ARG A 371TYR A 406 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.97A | 3k39P-4mjuA:51.6 | 3k39P-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.56A | 3sanA-4mjuA:72.4 | 3sanA-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.99A | 3sanA-4mjuA:72.4 | 3sanA-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.79A | 3sanA-4mjuA:72.4 | 3sanA-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 3sanB-4mjuA:72.4 | 3sanB-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.98A | 3sanB-4mjuA:72.4 | 3sanB-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.23A | 3sanB-4mjuA:72.4 | 3sanB-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.82A | 3sanB-4mjuA:72.4 | 3sanB-4mjuA:69.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.55A | 3ti5A-4mjuA:67.7 | 3ti5A-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.04A | 3ti5A-4mjuA:67.7 | 3ti5A-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.65A | 3ti5A-4mjuA:67.7 | 3ti5A-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.55A | 3ti5B-4mjuA:67.7 | 3ti5B-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.03A | 3ti5B-4mjuA:67.7 | 3ti5B-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.65A | 3ti5B-4mjuA:67.7 | 3ti5B-4mjuA:56.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151TRP A 178GLU A 227ALA A 246ASN A 294 | 27S A 501 (-3.0A)27S A 501 (-3.2A)None27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.6A) | 0.84A | 3ticA-4mjuA:62.7 | 3ticA-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118TRP A 178GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.58A | 3ticA-4mjuA:62.7 | 3ticA-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119TRP A 178ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)None27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.10A | 3ticA-4mjuA:62.7 | 3ticA-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156ILE A 222ARG A 224 | None27S A 501 (-4.2A)None27S A 501 ( 4.6A)27S A 501 (-4.3A) | 0.57A | 3ticA-4mjuA:62.7 | 3ticA-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 3ticB-4mjuA:62.7 | 3ticB-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.87A | 3ticB-4mjuA:62.7 | 3ticB-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.00A | 3ticB-4mjuA:62.7 | 3ticB-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.62A | 3ticB-4mjuA:62.7 | 3ticB-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 3ticC-4mjuA:62.8 | 3ticC-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.90A | 3ticC-4mjuA:62.8 | 3ticC-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.00A | 3ticC-4mjuA:62.8 | 3ticC-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.62A | 3ticC-4mjuA:62.8 | 3ticC-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 3ticD-4mjuA:62.7 | 3ticD-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.89A | 3ticD-4mjuA:62.7 | 3ticD-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.01A | 3ticD-4mjuA:62.7 | 3ticD-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.58A | 3ticD-4mjuA:62.7 | 3ticD-4mjuA:42.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 4b7nA-4mjuA:67.2 | 4b7nA-4mjuA:53.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.99A | 4b7nA-4mjuA:67.2 | 4b7nA-4mjuA:53.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.69A | 4b7nA-4mjuA:67.2 | 4b7nA-4mjuA:53.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4b7qA-4mjuA:67.4 | 4b7qA-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.03A | 4b7qA-4mjuA:67.4 | 4b7qA-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | 27S A 501 (-4.2A)None27S A 501 ( 4.6A) | 0.69A | 4b7qA-4mjuA:67.4 | 4b7qA-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.60A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-4.6A) | 0.86A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.06A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | None27S A 501 (-4.2A)NoneNone | 0.67A | 4b7qB-4mjuA:67.6 | 4b7qB-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-4.6A) | 0.83A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.09A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | 27S A 501 (-4.2A)None27S A 501 ( 4.6A) | 0.69A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.62A | 4b7qD-4mjuA:67.6 | 4b7qD-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151GLU A 227ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.71A | 4b7qD-4mjuA:67.6 | 4b7qD-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.06A | 4b7qD-4mjuA:67.6 | 4b7qD-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.68A | 4b7qD-4mjuA:67.6 | 4b7qD-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 4cpnA-4mjuA:52.2 | 4cpnA-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151GLU A 227ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.73A | 4cpnA-4mjuA:52.2 | 4cpnA-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.09A | 4cpnA-4mjuA:52.2 | 4cpnA-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.29A | 4cpnA-4mjuA:52.2 | 4cpnA-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A) | 0.65A | 4cpnA-4mjuA:52.2 | 4cpnA-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 4cpnB-4mjuA:52.0 | 4cpnB-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 156GLU A 227GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)None27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.65A | 4cpnB-4mjuA:52.0 | 4cpnB-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.08A | 4cpnB-4mjuA:52.0 | 4cpnB-4mjuA:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.77A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.22A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.06A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.21A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178 | None27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone | 0.74A | 4cpzA-4mjuA:52.1 | 4cpzA-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.68A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.50A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.15A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.05A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.24A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | 27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone | 0.82A | 4cpzB-4mjuA:52.0 | 4cpzB-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.70A | 4cpzC-4mjuA:52.1 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.53A | 4cpzC-4mjuA:52.1 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151GLU A 227GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.66A | 4cpzC-4mjuA:52.1 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.13A | 4cpzC-4mjuA:52.1 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.03A | 4cpzC-4mjuA:52.1 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.66A | 4cpzC-4mjuA:52.0 | 4cpzC-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.72A | 4cpzD-4mjuA:51.9 | 4cpzD-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.53A | 4cpzD-4mjuA:51.9 | 4cpzD-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.20A | 4cpzD-4mjuA:51.9 | 4cpzD-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.09A | 4cpzD-4mjuA:51.9 | 4cpzD-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | 27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone | 0.80A | 4cpzD-4mjuA:51.9 | 4cpzD-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.78A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227GLU A 277TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.69A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 1.24A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.10A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.69A | 4cpzE-4mjuA:52.0 | 4cpzE-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.79A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.56A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151GLU A 227GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.24A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.11A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.28A | 4cpzF-4mjuA:51.9 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.65A | 4cpzF-4mjuA:52.0 | 4cpzF-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.75A | 4cpzG-4mjuA:51.8 | 4cpzG-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.49A | 4cpzG-4mjuA:51.8 | 4cpzG-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.19A | 4cpzG-4mjuA:51.8 | 4cpzG-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.02A | 4cpzG-4mjuA:51.8 | 4cpzG-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.60A | 4cpzG-4mjuA:51.8 | 4cpzG-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.79A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.58A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 224GLU A 227ALA A 246ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.93A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.26A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.11A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | 27S A 501 (-4.2A)NoneNone | 0.64A | 4cpzH-4mjuA:51.9 | 4cpzH-4mjuA:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 152ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.54A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.68A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151ARG A 152GLU A 227ALA A 246TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-4.6A) | 0.91A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 152GLU A 119ALA A 246ARG A 371TYR A 406 | 27S A 501 (-4.2A)27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.30A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152GLU A 119ALA A 246TYR A 406 | 27S A 501 (-3.2A)27S A 501 (-4.2A)27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-4.6A) | 1.40A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 152ARG A 224ALA A 246GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.11A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 156TRP A 178ILE A 222ASN A 294 | NoneNoneNone27S A 501 ( 4.6A)27S A 501 (-3.6A) | 1.04A | 4i00A-4mjuA:62.9 | 4i00A-4mjuA:46.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.58A | 4mwrA-4mjuA:62.5 | 4mwrA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 0.99A | 4mwrA-4mjuA:62.5 | 4mwrA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152TRP A 178ILE A 222 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 ( 4.6A) | 0.63A | 4mwrA-4mjuA:62.5 | 4mwrA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)None27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.98A | 4mwvA-4mjuA:62.5 | 4mwvA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.42A | 4mwvA-4mjuA:62.5 | 4mwvA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | None27S A 501 (-3.2A)27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A) | 0.72A | 4mwvA-4mjuA:62.5 | 4mwvA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118GLU A 227ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-3.3A)27S A 501 (-3.1A) | 0.33A | 4mwvA-4mjuA:62.5 | 4mwvA-4mjuA:44.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.61A | 4mwxA-4mjuA:62.5 | 4mwxA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.69A | 4mwxA-4mjuA:62.5 | 4mwxA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 1.02A | 4mwxA-4mjuA:62.5 | 4mwxA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152TRP A 178ILE A 222 | 27S A 501 (-4.2A)None27S A 501 ( 4.6A) | 0.15A | 4mwxA-4mjuA:62.5 | 4mwxA-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119LEU A 134ARG A 152TRP A 178ARG A 224ALA A 246GLU A 276GLU A 277TYR A 406 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 1.05A | 4mx0A-4mjuA:62.4 | 4mx0A-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | None27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-4.6A) | 0.44A | 4mx0A-4mjuA:62.4 | 4mx0A-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ASP A 151ARG A 371 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.1A) | 0.74A | 4mx0A-4mjuA:62.4 | 4mx0A-4mjuA:43.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ASP A 151GLU A 227ALA A 246GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.59A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151GLU A 119TYR A 347ARG A 371TYR A 406 | 27S A 501 (-3.2A)27S A 501 (-3.4A)None27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.32A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ALA A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.94A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 227ALA A 246ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.15A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | 27S A 501 (-4.2A)NoneNone27S A 501 ( 4.6A)27S A 501 (-4.3A) | 0.69A | 4wa5A-4mjuA:74.1 | 4wa5A-4mjuA:90.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.52A | 5l17A-4mjuA:62.7 | 5l17A-4mjuA:43.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 118ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.77A | 5l17A-4mjuA:62.7 | 5l17A-4mjuA:43.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.95A | 5l17A-4mjuA:62.7 | 5l17A-4mjuA:43.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152TRP A 178ILE A 222 | None27S A 501 (-4.2A)None27S A 501 ( 4.6A) | 0.30A | 5l17A-4mjuA:62.7 | 5l17A-4mjuA:43.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MQT_A_STIA302_1 (DEOXYCYTIDINE KINASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | VAL A 398GLU A 277PHE A 422SER A 279GLU A 375 | None27S A 501 (-3.4A)NoneNoneNone | 1.41A | 5mqtA-4mjuA:undetectable | 5mqtA-4mjuA:18.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.40A | 6ekuA-4mjuA:12.2 | 6ekuA-4mjuA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276ARG A 292ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.1A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.68A | 6hcxA-4mjuA:62.5 | 6hcxA-4mjuA:14.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A) | 0.82A | 6hcxA-4mjuA:62.5 | 6hcxA-4mjuA:14.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 152ARG A 224ALA A 246GLU A 276ARG A 292TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 1.15A | 6hcxA-4mjuA:62.5 | 6hcxA-4mjuA:14.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
4mju | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | TRP A 178ILE A 222GLU A 277 | None27S A 501 ( 4.6A)27S A 501 (-3.4A) | 0.08A | 6hcxA-4mjuA:62.5 | 6hcxA-4mjuA:14.34 |